Skip to main content
. 2010 Jan 20;84(7):3586–3594. doi: 10.1128/JVI.01975-09

FIG. 4.

FIG. 4.

Time course and efficacy of TCD8+ activation after i.d. infection with AdCMVNP or AdK14NP. Mice were immunized i.d. and tested for either the ability to stimulate proliferation of adoptively transferred F5 TCD8+ via CFDA-SE dilution (A and B) or the effector activity via clearance of specific peptide-pulsed CFDA-SEHI labeled targets (C) on day 3 (A) or days 2, 3, and 4 (B and C) postinfection. (A) The site of infection was removed at the times shown postinfection. (D) The sensitivity of effector F5 TCD8+ was assessed by measuring the clearance of cells pulsed with various amounts of NP366-374 peptide 6 days after i.d. immunization. The data in panel C are expressed as a percentage of the maximal killing of NP366-374 peptide-pulsed CFDA-SEHI cells compared to levels after immunization with AdSPCNP. *, P < 0.05; **, P < 0.01.